ProfileGDS4718 / 231024_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 50% 52% 54% 59% 58% 52% 51% 44% 50% 50% 56% 56% 44% 52% 47% 42% 39% 46% 50% 46% 49% 54% 45% 57% 48% 58% 62% 68% 53% 55% 47% 51% 51% 40% 46% 36% 53% 50% 53% 58% 48% 46% 55% 41% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.5102350
GSM549102patient 115, normal, homogenized [OPG study]5.6573652
GSM549104patient 119, normal, homogenized [OPG study]5.7157154
GSM549108patient 138, normal, homogenized [OPG study]6.0920759
GSM549119patient 077, normal, homogenized [OPG study]5.9955258
GSM549133patient 032, cancer, homogenized [OPG study]5.573352
GSM549139patient 042, cancer, homogenized [OPG study]5.5738351
GSM549099patient 107, normal, homogenized [OPG study]5.2013244
GSM549109patient 139, normal, homogenized [OPG study]5.5580850
GSM549110patient 046, normal, homogenized [OPG study]5.4975650
GSM549114patient 063, normal, homogenized [OPG study]5.7911456
GSM549122patient 082, normal, homogenized [OPG study]5.893756
GSM549134patient 033, cancer, homogenized [OPG study]5.1705944
GSM549136patient 036, cancer, homogenized [OPG study]5.5654652
GSM549140patient 044, cancer, homogenized [OPG study]5.3324147
GSM549111patient 047, normal, homogenized [OPG study]5.0680642
GSM549113patient 057, normal, homogenized [OPG study]4.8642739
GSM549132patient 031, cancer, homogenized [OPG study]5.266446
GSM549137patient 038, cancer, homogenized [OPG study]5.527550
GSM549142patient 047, cancer, homogenized [OPG study]5.410446
GSM549100patient 110, normal, homogenized [OPG study]5.4794849
GSM549107patient 135, normal, homogenized [OPG study]5.7427154
GSM549115patient 068, normal, homogenized [OPG study]5.1616545
GSM549116patient 072, normal, homogenized [OPG study]5.9413857
GSM549120patient 078, normal, homogenized [OPG study]5.4212648
GSM549131patient 030, cancer, homogenized [OPG study]5.9789458
GSM549118patient 074, normal, homogenized [OPG study]6.2579562
GSM549129patient 027, cancer, homogenized [OPG study]6.8003568
GSM549123patient 088, normal, homogenized [OPG study]5.6550753
GSM549124patient 006, cancer, homogenized [OPG study]5.8127855
GSM549126patient 015, cancer, homogenized [OPG study]5.3166347
GSM549128patient 025, cancer, homogenized [OPG study]5.5732251
GSM549103patient 117, normal, homogenized [OPG study]5.6037751
GSM549117patient 073, normal, homogenized [OPG study]4.9605640
GSM549138patient 041, cancer, homogenized [OPG study]5.2960446
GSM549141patient 045, cancer, homogenized [OPG study]4.755536
GSM549130patient 028, cancer, homogenized [OPG study]5.6631553
GSM549101patient 111, normal, homogenized [OPG study]5.5684450
GSM549105patient 128, normal, homogenized [OPG study]5.7303953
GSM549106patient 134, normal, homogenized [OPG study]5.9563958
GSM549112patient 048, normal, homogenized [OPG study]5.3937848
GSM549125patient 011, cancer, homogenized [OPG study]5.3201746
GSM549127patient 024, cancer, homogenized [OPG study]5.8119255
GSM549135patient 035, cancer, homogenized [OPG study]4.9853841